Virtus ETF Advisers LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Virtus ETF Advisers LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$83.14 - $145.99 $297,225 - $521,914	-3,575 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $98,034 - $145,955	-983 Reduced 21.57%	3,575 $493,000
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $41,022 - $57,647	-415 Reduced 8.35%	4,558 $633,000
Q2 2021 Aug 10, 2021	SELL	$65.78 - $105.02 $146,031 - $233,144	-2,220 Reduced 30.86%	4,973 $483,000
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $12,557 - $17,983	196 Added 2.8%	7,193 $492,000
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $151,352 - $228,506	2,326 Added 49.8%	6,997 $600,000
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $38,198 - $50,433	-647 Reduced 12.17%	4,671 $304,000
Q2 2020 Aug 05, 2020	SELL	$29.01 - $74.23 $44,646 - $114,239	-1,539 Reduced 22.44%	5,318 $389,000
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $27,592 - $57,461	-1,003 Reduced 12.76%	6,857 $233,000
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $156,657 - $221,030	3,834 Added 95.23%	7,860 $428,000
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $8,335 - $11,031	-223 Reduced 5.25%	4,026 $168,000
Q2 2019 Aug 13, 2019	SELL	$39.79 - $67.01 $125,736 - $211,751	-3,160 Reduced 42.65%	4,249 $186,000
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $31,447 - $48,547	-911 Reduced 10.95%	7,409 $381,000
Q4 2018 Feb 05, 2019	SELL	$29.75 - $42.9 $98,323 - $141,784	-3,305 Reduced 28.43%	8,320 $308,000
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $279,665 - $366,747	-8,529 Reduced 42.32%	11,625 $437,000
Q2 2018 Aug 10, 2018	BUY	$23.62 - $42.29 $476,037 - $852,312	20,154 New	20,154 $796,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.